Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations: Beerse, Belgium Monday, February 2, 2026, ...

President Biden has started a new phase of treatment for an aggressive form of prostate cancer, which includes radiation and hormone therapy, according to new reports on Saturday. “As part of a ...

Prostate cancer (PCa) remains a significant global health challenge, with rising morbidity rates and poor prognosis associated with advanced stages ...

“A Gleason score of 9.” Veterans of prostate cancer will know those five words pack a punch. It is a grade-high diagnosis, meaning not only that cancer cells are aggressive but that they can spread ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. Technology ...

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...